SCIENTX Stock Overview
Scientex Berhad, an investment holding company, manufactures and sells various packaging products.
Scientex Berhad Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||RM3.47|
|52 Week High||RM5.00|
|52 Week Low||RM3.37|
|1 Month Change||-0.86%|
|3 Month Change||-14.32%|
|1 Year Change||-17.97%|
|3 Year Change||20.49%|
|5 Year Change||18.30%|
|Change since IPO||3,007.54%|
Recent News & Updates
Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting Stock
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
|SCIENTX||MY Chemicals||MY Market|
Return vs Industry: SCIENTX underperformed the MY Chemicals industry which returned 9.3% over the past year.
Return vs Market: SCIENTX underperformed the MY Market which returned -8.7% over the past year.
|SCIENTX Average Weekly Movement||3.2%|
|Chemicals Industry Average Movement||5.0%|
|Market Average Movement||5.5%|
|10% most volatile stocks in MY Market||11.4%|
|10% least volatile stocks in MY Market||2.9%|
Stable Share Price: SCIENTX is less volatile than 75% of MY stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: SCIENTX's weekly volatility (3%) has been stable over the past year.
About the Company
|1968||3,600||Peng Jin Lim||https://www.scientex.com.my|
Scientex Berhad, an investment holding company, manufactures and sells various packaging products. It operates in two segments, Packaging and Property Development. The company offers various packaging products, such as stretch films, polypropylene (PP) strapping bands, FIBC bags, HDPE and PP tying tapes, and form-fill and seal bags.
Scientex Berhad Fundamentals Summary
|SCIENTX fundamental statistics|
Is SCIENTX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SCIENTX income statement (TTM)|
|Cost of Revenue||RM2.81b|
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.28|
|Net Profit Margin||11.12%|
How did SCIENTX perform over the long term?See historical performance and comparison
2.6%Current Dividend Yield
Does SCIENTX pay a reliable dividends?See SCIENTX dividend history and benchmarks
|Scientex Berhad dividend dates|
|Ex Dividend Date||Jul 07 2022|
|Dividend Pay Date||Jul 22 2022|
|Days until Ex dividend||11 days|
|Days until Dividend pay date||26 days|
Does SCIENTX pay a reliable dividends?See SCIENTX dividend history and benchmarks
Is SCIENTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SCIENTX?
Other financial metrics that can be useful for relative valuation.
|What is SCIENTX's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does SCIENTX's PE Ratio compare to its peers?
|SCIENTX PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: SCIENTX is expensive based on its Price-To-Earnings Ratio (12.6x) compared to the peer average (6.9x).
Price to Earnings Ratio vs Industry
How does SCIENTX's PE Ratio compare vs other companies in the Chemicals Industry?
Price-To-Earnings vs Industry: SCIENTX is expensive based on its Price-To-Earnings Ratio (12.6x) compared to the MY Chemicals industry average (12.6x)
Price to Earnings Ratio vs Fair Ratio
What is SCIENTX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||12.6x|
|Fair PE Ratio||20.6x|
Price-To-Earnings vs Fair Ratio: SCIENTX is good value based on its Price-To-Earnings Ratio (12.6x) compared to the estimated Fair Price-To-Earnings Ratio (20.6x).
Share Price vs Fair Value
What is the Fair Price of SCIENTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SCIENTX (MYR3.47) is trading below our estimate of fair value (MYR6.69)
Significantly Below Fair Value: SCIENTX is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: SCIENTX is good value based on its PEG Ratio (0.7x)
Discover undervalued companies
How is Scientex Berhad forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SCIENTX's forecast earnings growth (18% per year) is above the savings rate (3.6%).
Earnings vs Market: SCIENTX's earnings (18% per year) are forecast to grow faster than the MY market (9.9% per year).
High Growth Earnings: SCIENTX's earnings are forecast to grow, but not significantly.
Revenue vs Market: SCIENTX's revenue (11.8% per year) is forecast to grow faster than the MY market (5.2% per year).
High Growth Revenue: SCIENTX's revenue (11.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SCIENTX's Return on Equity is forecast to be low in 3 years time (15.9%).
Discover growth companies
How has Scientex Berhad performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SCIENTX has high quality earnings.
Growing Profit Margin: SCIENTX's current net profit margins (11.1%) are lower than last year (12.5%).
Past Earnings Growth Analysis
Earnings Trend: SCIENTX's earnings have grown by 13.8% per year over the past 5 years.
Accelerating Growth: SCIENTX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SCIENTX had negative earnings growth (-6.4%) over the past year, making it difficult to compare to the Chemicals industry average (15.6%).
Return on Equity
High ROE: SCIENTX's Return on Equity (14%) is considered low.
Discover strong past performing companies
How is Scientex Berhad's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SCIENTX's short term assets (MYR1.9B) exceed its short term liabilities (MYR1.8B).
Long Term Liabilities: SCIENTX's short term assets (MYR1.9B) exceed its long term liabilities (MYR431.9M).
Debt to Equity History and Analysis
Debt Level: SCIENTX's net debt to equity ratio (36.6%) is considered satisfactory.
Reducing Debt: SCIENTX's debt to equity ratio has reduced from 43.4% to 40.2% over the past 5 years.
Debt Coverage: SCIENTX's debt is well covered by operating cash flow (53.4%).
Interest Coverage: SCIENTX's interest payments on its debt are well covered by EBIT (26.2x coverage).
Discover healthy companies
What is Scientex Berhad current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: SCIENTX's dividend (2.59%) is higher than the bottom 25% of dividend payers in the MY market (2.15%).
High Dividend: SCIENTX's dividend (2.59%) is low compared to the top 25% of dividend payers in the MY market (4.91%).
Stability and Growth of Payments
Stable Dividend: SCIENTX's dividend payments have been volatile in the past 10 years.
Growing Dividend: SCIENTX's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (32.6%), SCIENTX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (27.9%), SCIENTX's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Peng Jin Lim (54 yo)
Mr. Peng Jin Lim has been the Managing Director of Scientex Packaging Berhad (formerly Woventex Corporation Berhad) since October 18, 2001. Mr. Lim has been the Managing Director of Scientex Berhad since N...
CEO Compensation Analysis
Compensation vs Market: Peng Jin's total compensation ($USD27.28K) is below average for companies of similar size in the MY market ($USD501.94K).
Compensation vs Earnings: Peng Jin's compensation has been consistent with company performance over the past year.
Experienced Management: SCIENTX's management team is seasoned and experienced (14.4 years average tenure).
Experienced Board: SCIENTX's board of directors are seasoned and experienced ( 13.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Scientex Berhad's employee growth, exchange listings and data sources
- Name: Scientex Berhad
- Ticker: SCIENTX
- Exchange: KLSE
- Founded: 1968
- Industry: Commodity Chemicals
- Sector: Materials
- Implied Market Cap: RM5.382b
- Shares outstanding: 1.55b
- Website: https://www.scientex.com.my
Number of Employees
- Scientex Berhad
- No. 9, Persiaran Selangor
- Seksyen 15
- Shah Alam
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/25 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.